These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 21678351)

  • 1. Evaluation of follow-up strategies for patients with epithelial ovarian cancer following completion of primary treatment.
    Kew F; Galaal K; Bryant A; Naik R
    Cochrane Database Syst Rev; 2011 Jun; (6):CD006119. PubMed ID: 21678351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of follow-up strategies for patients with epithelial ovarian cancer following completion of primary treatment.
    Clarke T; Galaal K; Bryant A; Naik R
    Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD006119. PubMed ID: 25198378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of follow-up strategies for women with epithelial ovarian cancer following completion of primary treatment.
    Zachou G; El-Khouly F; Dilley J
    Cochrane Database Syst Rev; 2023 Aug; 8(8):CD006119. PubMed ID: 37650760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal primary surgical treatment for advanced epithelial ovarian cancer.
    Elattar A; Bryant A; Winter-Roach BA; Hatem M; Naik R
    Cochrane Database Syst Rev; 2011 Aug; 2011(8):CD007565. PubMed ID: 21833960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical cytoreduction for recurrent epithelial ovarian cancer.
    Al Rawahi T; Lopes AD; Bristow RE; Bryant A; Elattar A; Chattopadhyay S; Galaal K
    Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD008765. PubMed ID: 23450588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultra-radical (extensive) surgery versus standard surgery for the primary cytoreduction of advanced epithelial ovarian cancer.
    Ang C; Chan KK; Bryant A; Naik R; Dickinson HO
    Cochrane Database Syst Rev; 2011 Apr; (4):CD007697. PubMed ID: 21491400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Luteinising hormone releasing hormone (LHRH) agonists for the treatment of relapsed epithelial ovarian cancer.
    Wuntakal R; Seshadri S; Montes A; Lane G
    Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD011322. PubMed ID: 27356090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon after surgery for women with advanced (Stage II-IV) epithelial ovarian cancer.
    Lawal AO; Musekiwa A; Grobler L
    Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD009620. PubMed ID: 23740789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen-specific active immunotherapy for ovarian cancer.
    Leffers N; Daemen T; Helfrich W; Boezen HM; Cohlen BJ; Melief CJ; Nijman HW
    Cochrane Database Syst Rev; 2014 Sep; (9):CD007287. PubMed ID: 25229990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interventions for the treatment of borderline ovarian tumours.
    Faluyi O; Mackean M; Gourley C; Bryant A; Dickinson HO
    Cochrane Database Syst Rev; 2010 Sep; 2010(9):CD007696. PubMed ID: 20824864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer.
    Winter-Roach BA; Kitchener HC; Dickinson HO
    Cochrane Database Syst Rev; 2009 Jan; (1):CD004706. PubMed ID: 19160239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal growth factor receptor blockers for the treatment of ovarian cancer.
    Haldar K; Gaitskell K; Bryant A; Nicum S; Kehoe S; Morrison J
    Cochrane Database Syst Rev; 2011 Oct; (10):CD007927. PubMed ID: 21975775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Centralisation of services for gynaecological cancer.
    Woo YL; Kyrgiou M; Bryant A; Everett T; Dickinson HO
    Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD007945. PubMed ID: 22419327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer.
    Winter-Roach BA; Kitchener HC; Dickinson HO
    Cochrane Database Syst Rev; 2009 Jul; (3):CD004706. PubMed ID: 19588360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoradiation for advanced primary vulval cancer.
    Shylasree TS; Bryant A; Howells RE
    Cochrane Database Syst Rev; 2011 Apr; 2011(4):CD003752. PubMed ID: 21491387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follow-up protocols for women with cervical cancer after primary treatment.
    Lanceley A; Fiander A; McCormack M; Bryant A
    Cochrane Database Syst Rev; 2013 Nov; 2013(11):CD008767. PubMed ID: 24277645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer.
    Galaal K; Naik R; Bristow RE; Patel A; Bryant A; Dickinson HO
    Cochrane Database Syst Rev; 2010 Jun; 2010(6):CD007822. PubMed ID: 20556785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Palliative surgery versus medical management for bowel obstruction in ovarian cancer.
    Kucukmetin A; Naik R; Galaal K; Bryant A; Dickinson HO
    Cochrane Database Syst Rev; 2010 Jul; 2010(7):CD007792. PubMed ID: 20614464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is immediate imaging important in managing low back pain?
    Andersen JC
    J Athl Train; 2011; 46(1):99-102. PubMed ID: 21214357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interval debulking surgery for advanced epithelial ovarian cancer.
    Tangjitgamol S; Manusirivithaya S; Laopaiboon M; Lumbiganon P; Bryant A
    Cochrane Database Syst Rev; 2010 Oct; (10):CD006014. PubMed ID: 20927744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.